Human Centriole and Centrosome Antibody IgG ELISA Kit |
|
MBS039049-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human IgG antibody Laboratories manufactures the leebiosolutions reagents distributed by Genprice. The Leebiosolutions reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Lee Biosolutions Ltd.. Other Leebiosolutions products are available in stock. Specificity: Leebiosolutions Category:
Human True insulin ELISA kit |
|
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
|
BlueGene |
48 wells plate |
EUR 280 |
Human True insulin ELISA kit |
|
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
|
BlueGene |
96 wells plate |
EUR 405 |
Human True Insulin GENLISA ELISA |
|
Krishgen |
1 x 96 wells |
EUR 286 |
Human True Insulin ELISA Kit |
|
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human True Insulin ELISA Kit |
|
MyBiosource |
48-Strip-Wells |
EUR 550 |
Chemicals information
LEE011 succinate |
|
B1084-10 |
ApexBio |
10 mg |
EUR 64 |
|
|
|
Description: Cell Cycle/Checkpoint|Cyclin-Dependent Kinases |
LEE011 succinate |
|
B1084-100 |
ApexBio |
100 mg |
EUR 420 |
|
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
|
B1084-200 |
ApexBio |
200 mg |
EUR 640.8 |
|
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
|
B1084-25 |
ApexBio |
25mg |
EUR 160 |
|
|
|
Description: Cell Cycle/Checkpoint|Cyclin-Dependent Kinases |
LEE011 succinate |
|
B1084-5 |
ApexBio |
5 mg |
EUR 48 |
|
|
|
Description: Cell Cycle/Checkpoint|Cyclin-Dependent Kinases |
LEE011 succinate |
|
B1084-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 192 |
|
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
|
B1084-50 |
ApexBio |
50 mg |
EUR 112 |
|
|
|
Description: Cell Cycle/Checkpoint|Cyclin-Dependent Kinases |
LEE011 succinate |
|
B1084-500 |
ApexBio |
500 mg |
EUR 1101.6 |
|
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
Ribociclib (LEE011) |
|
9481-25 |
Biovision |
each |
EUR 548.4 |
Ribociclib (LEE011) |
|
9481-5 |
Biovision |
each |
EUR 183.6 |
LEE011 (Ribociclib) |
|
MBS385032-10mg |
MyBiosource |
10mg |
EUR 170 |
LEE011 (Ribociclib) |
|
MBS385032-25mg |
MyBiosource |
25mg |
EUR 210 |
